Your browser doesn't support javascript.
loading
Impact of Tumor Grade Distribution on Genetic Alterations in Clear Cell Renal Cell Carcinoma and Prostate Cancer.
Mizutani, Kosuke; Sugiyama, Seiji; Kameyama, Koji; Kamei, Shingo; Yokoi, Shigeaki; Morikawa, Akemi; Takeuchi, Makoto; Seike, Kensaku; Yamada, Toru; Ehara, Hidetoshi; Sawada, Seiya; Hirade, Kouseki; Furuta, Hirohito; Matsunaga, Kengo; Yamada, Tetsuya; Sakamoto, Ippei; Kato, Yasutaka; Nishihara, Hiroshi; Ishihara, Satoshi; Deguchi, Takashi.
Afiliação
  • Mizutani K; Department of Urology, Central Japan International Medical Center, Minokamo, Japan; k-mizutani@cjimc-hp.jp.
  • Sugiyama S; Cancer Genomic Testing & Treatment Center, Central Japan International Medical Center, Minokamo, Japan.
  • Kameyama K; Department of Pathology, Central Japan International Medical Center, Minokamo, Japan.
  • Kamei S; Department of Urology, Central Japan International Medical Center, Minokamo, Japan.
  • Yokoi S; Department of Urology, Central Japan International Medical Center, Minokamo, Japan.
  • Morikawa A; Department of Urology, Central Japan International Medical Center, Minokamo, Japan.
  • Takeuchi M; Department of Breast Surgery, Central Japan International Medical Center, Minokamo, Japan.
  • Seike K; Department of Breast Surgery, Central Japan International Medical Center, Minokamo, Japan.
  • Yamada T; Department of Urology, Chuno Kosei Hospital, Seki, Japan.
  • Ehara H; Department of Urology, Tokai Central Hospital, Kakamigahara, Japan.
  • Sawada S; Department of Urology, Asahi University Hospital, Gifu, Japan.
  • Hirade K; Cancer Genomic Testing & Treatment Center, Central Japan International Medical Center, Minokamo, Japan.
  • Furuta H; Cancer Genomic Testing & Treatment Center, Central Japan International Medical Center, Minokamo, Japan.
  • Matsunaga K; Department of Clinical Laboratory, Central Japan International Medical Center, Minokamo, Japan.
  • Yamada T; Department of Pathology, Central Japan International Medical Center, Minokamo, Japan.
  • Sakamoto I; Department of Pathology, Central Japan International Medical Center, Minokamo, Japan.
  • Kato Y; Bioinformatics Department, Communication Engineering Center, Electronic Systems Business Group, Mitsubishi Electric Software Corporation, Hamamatsu-cho, Japan.
  • Nishihara H; Genomics Unit, Keio Cancer Center, Keio University School of Medicine, Shinjuku, Japan.
  • Ishihara S; Genomics Unit, Keio Cancer Center, Keio University School of Medicine, Shinjuku, Japan.
  • Deguchi T; Department of Urology, Central Japan International Medical Center, Minokamo, Japan.
Cancer Genomics Proteomics ; 21(2): 203-212, 2024.
Article em En | MEDLINE | ID: mdl-38423595
ABSTRACT
BACKGROUND/

AIM:

A genomic analysis based on next-generation sequencing is important for deciding cancer treatment strategies. Cancer tissue sometimes displays intratumor heterogeneity and a pathologic specimen may contain more than two tumor grades. Although tumor grades are very important for the cancer prognosis, the impact of higher tumor grade distribution in a specimen used for a genomic analysis is unknown. PATIENTS AND

METHODS:

We retrospectively analyzed the data of 61 clear cell carcinoma and 46 prostate cancer patients that were diagnosed between December 2018 and August 2022 using the GeneRead Human Comprehensive Cancer Panel or SureSelect PrePool custom Tier2. Genome annotation and curation were performed using the GenomeJack software.

RESULTS:

Tumor mutation burden (TMB) was increased in proportion to the higher tumor grade distribution in grade 2 clear cell renal cell carcinoma (ccRCC). In PC, Grade Group 3/4 specimens that included an increased distribution of Gleason pattern 4 had more frequent gene mutations.

CONCLUSION:

Our results suggest the importance of selecting the maximum distribution of higher tumor grade areas to obtain results on the precise gene alterations for genomics-focused treatments.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Carcinoma de Células Renais / Neoplasias Renais Limite: Humans / Male Idioma: En Revista: Cancer Genomics Proteomics Assunto da revista: BIOQUIMICA / GENETICA MEDICA / NEOPLASIAS Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Carcinoma de Células Renais / Neoplasias Renais Limite: Humans / Male Idioma: En Revista: Cancer Genomics Proteomics Assunto da revista: BIOQUIMICA / GENETICA MEDICA / NEOPLASIAS Ano de publicação: 2024 Tipo de documento: Article